Verona Pharma recently announced the company’s accomplishments in the last six months, including an update to the company’s clinical trial in…
Patricia Inácio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inácio, PhD
The U.S. Food and Drug Administration (FDA) is advising patients and healthcare professionals to not use any liquid products made…
Concert Pharmaceuticals’ sale of its cystic fibrosis therapy CTP-656 to the larger Vertex Pharmaceuticals will lead to cystic fibrosis patients obtaining faster access…
Sweat from Infants with CF May Contain Biomarkers That Help Doctors Treat the Disease, Study Reports
Sweat from infants with cystic fibrosis contains substances that could be used as biomarkers of the disease and even identify…
A new method of isolating lung stem cells could help speed the development of stem-cell based therapies for lung diseases,…
In a groundbreaking study, scientists reported editing and correcting, for the first time, a defective gene in human…
A substance found in a Japanese cypress tree can deliver iron to cells that are unable to obtain it because…
Researchers at TGV-inhalonix said their company’s drug, Mul-1867, has a powerful effect against clinical isolates of fungi in patients with cystic fibrosis…
Scientists at Boston University’s Center for Regenerative Medicine have made two stem cell discoveries that could help doctors treat cystic…
Combined Tezacaftor, Kalydeco Therapy Significantly Improved CF Lung Function in Clinical Trials
Vertex Pharmaceuticals recently announced positive results of two Phase 3 clinical trials, the EVOLVE and EXPAND studies, evaluating the effects…